📰 Aadi Bioscience News
Page 8 - Aadi Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aadi Bioscience. Real-time updates on events, politics, business and more.
May 10, 2023
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically...
May 10, 2023
/PRNewswire/ -- DelveInsights Soft Tissue Sarcoma Pipeline Insight – 2023 report provides comprehensive global coverage of available, marketed, and pipeline...
May 10, 2023
The prevalence of soft tissue sarcoma has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of soft tissue sarcoma and the
May 4, 2023
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) Chairman Neil Desai sold 7,695 shares of the firm’s stock in a transaction on Wednesday, May 3rd. The shares were sold at an average price of $7.68, for a total value of $59,097.60. Following the completion of the transaction, the chairman now owns 1,833,848 shares of the company’s […]
May 4, 2023
Aadi Bioscience (NASDAQ:AADI – Get Rating) is scheduled to be issuing its quarterly earnings data before the market opens on Wednesday, May 10th. Analysts expect the company to announce earnings of ($0.58) per share for the quarter. Aadi Bioscience Stock Performance AADI traded down $0.11 during trading on Thursday, hitting $7.62. The stock had a […]
April 26, 2023
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...
April 15, 2023
Aadi Bioscience (NASDAQ:AADI – Get Rating) and Arvinas (NASDAQ:ARVN – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Valuation & Earnings This table compares Aadi Bioscience and Arvinas’ […]
April 13, 2023
Emma Reeve to support Editas’ evolution in new role as Chair of the Board Elliott Levy, M.D., joins Board as an Independent Director CAMBRIDGE, Mass., April 13, 2023 -- Editas... | April 13, 2023
April 10, 2023
Corporate Presentation April 2023 Forward-Looking Statements ... | April 10, 2023
April 8, 2023
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) Chairman Neil Desai sold 9,583 shares of the business’s stock in a transaction that occurred on Monday, April 3rd. The stock was sold at an average price of $7.45, for a total value of $71,393.35. Following the completion of the transaction, the chairman now directly owns 1,905,960 shares […]